Impilo's portfolio company Pelago Bioscience acquires RG Discovery
The deal combines Pelago's target engagement capabilities with RG Discovery's medicinal chemistry expertise, enabling full-cycle DMTA services for customers.
See the latest news and media coverage for Impilo. We track all announcements, press releases, and industry mentions in real time, all in one place.
Nordic healthcare investment company
impilo.seLast updated
In short: Impilo completed several healthcare acquisitions, formed a strategic partnership with KKR, and closed its second fund at a €700m hard cap.
The deal combines Pelago's target engagement capabilities with RG Discovery's medicinal chemistry expertise, enabling full-cycle DMTA services for customers.
The acquisition forms an integrated drug discovery partner spanning biology and chemistry.
KKR acquires Immedica, with Impilo reinvesting as equal owner. They support growth, Loargys launch, pipeline, and U.S. expansion.
The deal from Demant A/S marks the first investment in Fund II.
PHILADELPHIA, Nov. 14, 2024 /PRNewswire/ -- Impilo, the digital health platform on a mission to revolutionize healthcare access from anywhere, is thrilled to announce the...
Morgan Stanley’s private equity secondaries business and Hayfin have co-led a GP-led deal involving a drug company that was recently partially exited to KKR. The...
Humana's largest owner Impilo is positive to Ambea's bid and sees great opportunities in the care market going forward. If the bid goes through, steps...
Track Impilo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Impilo and other trending companies.